the more of there PR i read the more I am convinced that this will be a great announcement in the nest 2 weeks or less. They have finished all trial data as of feb 2015 and release is imminent, They have multiple source alternatives for the production faciity under contract. The FDA oversaw the second trial offering help throughout the process to help expedite it. The data points were lowered for trial 2. I just dont see how this doesnt get approved and then you look at fda approval of another heart drug with only a 22% reduction in hospitalization. I see this as getting production approval then it only comes down to usage by physicians for their patients if it doesnt get bought out upon approval.
into this stock was to buy stock and sell may 17.50 calls for a spread investment but today I have bought back 1/4 of those calls plus the additonal stock I added so that now 1/2 of the stock I own does not have calls sold against it. This is looking very bullish to me and we only have 2 weeks to go if their guidance at end of month is correct
this was basically the same reply that came out in the PR and it is unsatisfactory and I have over 50k shares. They way underperformed and the reason of no samples is a sad statement that does not answer the problem Should they not overperform next quarter i will exit rapidly as I will know that management is defunct.
it wasnt the note offering that taniked the stock that has been known for weeks, it was the guidance for this quarters revenuse 45% under estimates that killed it. This was a disaster of a quarter.
but none of that explains the big drop off in tresimet and being more than 40% off on sales, there is a lot of explaining to do about this quarter,it was awful like all the salesforce went on vacation and all the docs switched to other drugs.
this has been discussed ad infinitum. the secondary wont be done until they need to contract for the facility, finish it for production, hire staff and salespeople so forget your short thesis it is running out of time only 2 more weeks and it will be after lol
i know bthey have done biopsy on heart tissue in phase one and since none of the patients died i would assume it was on live patients i remember about reading the levels they were measuring
i usually see this when the MM knows that there is good news coming and he takes the bids in between to fill his book and occassionally sells to reduce when a full price offer comes in. to me this is bullish
I used to do carpentry for my dad when I was in high school all the way through graduate school. I loved it. I have been adding